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Background: Curcuminoids (curcumin, demethoxycurcumin, bis-demethoxycurcumin) are lipophilic polyphe-
nols thought to be effective in the prevention and treatment of neurodegenerative disorders, of whichmitochon-
drial dysfunction is a prominent feature. In particular, older people may thus beneﬁt from increasing their
curcuminoid intake. However until now, it is not investigated if there exist age differences in the bioavailability
of curcuminoids and therefore, it is unclear if curcumin doses have to be adjusted to age. Thus, we explored if the
tissue concentrations and biological activities of curcuminoids are affected by age.
Methods: We investigated age-differences in the bioavailability and tissue distribution of curcuminoids and mi-
tochondrial function in 3- and 18-months old mice fed a control diet or identical diets fortiﬁedwith 500 or 2000
mg curcuminoids/kg for 3 weeks. Therefore, we measured curcuminoid concentrations in plasma, liver, kidney,
and brain, basal and stress-induced levels of adenosine triphosphate (ATP) andmitochondrial membrane poten-
tial (MMP) in dissociated brain cells and citrate synthase activity of isolated mitochondria.
Results: Plasma but not liver and kidney curcuminoid concentrationswere signiﬁcantly higher in oldermice. Age
did not affect ATP concentrations andMMP in dissociated brain cells. After damaging cells with nitrosative stress,
dissociated brain cells from old mice had a higher MMP than cells from young animals and were therefore more
resistant. Furthermore, this effect was enhanced by curcumin.
Conclusion: Our data suggest that age may affect plasma concentrations, but not the tissue distribution of curcu-
minoids in mice, but has little impact on mitochondrial function in brain cells.
© 2015 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Curcuminoids are lipophilic polyphenols derived from the rhizome of
the plant Curcuma longa and responsible for the yellow color of turmeric.
Commercially available curcumin powders contain 75–85% curcumin,
15–20% demethoxycurcumin (DMC) and 2–8% bis-demethoxycurcumin
(BDMC) [1]. Curcuminoids are used as a spice and food additive (E100)
[2] and have long been used in Ayurvedic medicine for the treatment of
respiratory and liver disorders, anorexia, rheumatism, diabetic wounds,
runny nose, cough and sinusitis [7]. Curcumin, the major curcuminoid,
may be effective in the prevention [4] and treatment [13] of neurodegen-
erative disorders, of whichmitochondrial dysfunction is a prominent fea-
ture. Curcuminoids improve mitochondrial function and increase
mitochondrial membrane potential (MMP) and adenosine triphosphate
(ATP) concentrations in the brain of mice [6].. Kocher).
bH. This is an open access article undIn particular, older people may thus beneﬁt from increasing their
curcuminoid intake. The oral bioavailability of curcuminoids is low
[22] and the small fraction of absorbed curcuminoids is quickly metab-
olized by phase I and II enzymes and rapidly excreted from theorganism
[19,24]. During phase I metabolism, curcuminoids are reduced to
dihydro-, tetrahydro-, hexahydro-, and octahydrocurcminoids and dur-
ing phase II metabolism the reduced metabolites are conjugated with
glucuronic acid and sulphate in the liver and intestine [10,11]. Physio-
logical changes during aging, such as decreases in i) the absorption sur-
face in the gastro-intestinal tract, ii) hepatic blood ﬂow and mass, iii)
renal blood ﬂow and glomerular ﬁltration rate, and iv) increases in
total body fat, aswell as v) changes in the activity of metabolic enzymes
and transportersmay affect the bioavailability of curcuminoids. It is cur-
rently not known, however, if the absorption and tissue concentrations
of curcuminoids and consequently their biological activities are affected
by age.
We compared young (3-months) and old (18-months)mice fed cur-
cuminoids for three weeks to investigate if age impacts on curcuminoid
concentrations in tissues (plasma, liver, kidney, and brain) and alters
mitochondrial function in brain cells.er the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2.1. Animals and treatment
Thirty 3-months and thirty 18-months old male C57BL/6 mice were
purchased from Janvier Labs (Le Genest-Saint-Isle, France) and divided
into six groups of tenmice. Young (Y) and old (O)micewere fed either a
pelleted control diet (C1000, Altromin, Lage, Germany; control groups:
YC and OC, respectively) or the control diet supplemented with 500mg
curcumin (Y500 and O500, respectively) or 2000 mg curcumin per kg
diet (Y2000 and O2000, respectively) for 3 weeks. The curcuminoid ex-
tract used in the formulation of the diets was from Jupiter Leys (Cochin,
Kerala State, India) and contained 82% curcumin, 16% demethoxycurcu-
min (DMC), and 2% bis-demethoxycurcumin (BDMC). The mice had
free access to feed and water throughout the experiment and were
housed in groups of 5 animals per cage in a conditioned room (temper-
ature, 23 °C; relative humidity 55%; 12 h light/dark cycle). All experi-
ments were carried out by individuals with appropriate training
and experience according to the requirements of the Federation of
European Laboratory Animal Science Associations and the European
Communities Council Directive (Directive 2010/63/EU). Body weights
were measured weekly and at the end of the trial. The mice were
sacriﬁced by cervical dislocation and decapitation. Blood samples were
centrifuged in heparinized vials (1308 ×g, 5 min, 4 °C) and plasma sam-
ples were stored at−80 °C. Liver and kidney were rinsed with sodium
phosphate buffer, snap-frozen in liquid nitrogen and stored at−80 °C.
The brain was quickly processed on ice after displacement of the cere-
bellum and brain stem.
2.2. Quantiﬁcation of total curcuminoids
Sodium acetate buffer (0.1 M, pH 4–4.5) containing 1.6% EDTA
(48.8 μM) and 2.5% ascorbic acid (25 μM)were added to 100 μL plasma.
Tissue samples (~300mg liver or kidney in 400 μL buffer; ~100 mg cer-
ebellum in 200 μL buffer)were homogenized (Miccra D-8 homogenizer,
ART Prozess- und Labortechnik GmbH& Co. KG,Müllheim, Germany) in
the same buffer. Plasma and tissue sampleswere incubatedwith 1000U
β-glucuronidase (from Helix pomatia, Sigma, St. Louis, USA) dissolved
in 0.1M sodium acetate buffer (pH 4–4.5) for 45 min at 37 °C under ag-
itation. After incubation, 1 mL extraction solvent (95% ethyl acetate, 5%
methanol, Carl Roth GmbH + Co.KG, Karlsruhe, Germany) was added
and vortex -mixed for 30 s. Subsequently, samples were centrifuged
(10,500 ×g, 5 min, 4 °C) and supernatants collected. This step was
repeated twice. The organic layer was evaporated to dryness using
an RVC 2–25 CDplus centrifugal evaporator (Martin Christ
Gefriertrocknungsanlagen GmbH, Osterode am Harz, Germany).
Samples were re-suspended in 150 μL methanol, vortex-mixed for
30 s, left in the dark for 10 min, and vortex-mixed again for 20 s, and
then transferred to an injection vial. Curcuminoids were quantiﬁed on
a Jasco HPLC system (Jasco GmbH, Gross-Umstadt, Germany) with a
ﬂuorescence detector (excitation wavelength 426 nm, emission wave-
length 536 nm) and separated on a Reprosil-Pur C18-AQ column
(150 mm × 4 mm, 3 μm particle size; Dr. Maisch GmbH, Ammerbuch,
Germany) maintained at 40 °C. The mobile phase consisted of 52% de-
ionized water (adjusted to pH 3 with perchloric acid), 34% acetonitrile
and 14% methanol and was delivered at a ﬂow rate of 1.4 mL/min. Cur-
cuminoids were quantiﬁed against external standard curves (curcumin,
purity ≥97.2%, CAS # 458-37-7; demethoxycurcumin (DMC), purity
≥98.3%, CAS # 22608-11-13; bis-demethoxycurcumin (BDMC), purity
≥99.4%, CAS # 24939-16-0; Chromadex, Irvine, USA).
2.3. Preparation of dissociated brain cells
Dissociated brain cells (DBC) were prepared as previously described
[8,9]. After preparation, DBC were diluted in Dulbecco's Modiﬁed Eagle
Medium (DMEM) without supplements and seeded in 24-well plates(250 μL for measurement of mitochondrial membrane potential) or 96
well-plates (50 μL for measurement of adenosine triphosphate (ATP))
and cultured in a humidiﬁed incubator at 37 °C under 5% CO2. To induce
nitrosative damage, DBCwere incubated for 3 hwith sodium nitroprus-
side (SNP; 0.1 mmol/L for ATP measurements; 2 mmol/L for mitochon-
drial membrane potential measurements) in DMEM (Sigma-Aldrich
Chemie GmbH, Schnelldorf, Germany). The degree of damage caused
by SNP was calculated by normalization of the MMP and ATP values
after SNP incubation to the corresponding basal values.2.4. Determination of mitochondrial membrane potential
Mitochondrial membrane potential (MMP)wasmeasured in cultivat-
ed DBC using the ﬂuorescent dye Rhodamin 123 (R123) [6]. DBCwere in-
cubated in the dark for 15 min (37 °C, 5% CO2) with 0.4 μmol/L R123 and
then centrifuged (3000 rpm, 5 min) and washed with Hank's Balanced
Salt Solution (HBSS) buffer (supplemented with Mg2+, Ca2+, and 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES); pH 7.4; 37 °C).
After supplementing DBC with new HBSS, MMPwas assessed by reading
the R123 ﬂuorescence at an excitation wave- length of 490 nm and an
emission wavelength of 535 nm (Victor X3 2030 multilabel counter,
Perkin Elmer, Rodgau-Jügesheim, Germany). Fluorescence values were
normalized to cellular protein concentrations.2.5. Quantiﬁcation of adenosine triphosphate concentrations
The ViaLight® Plus bioluminescence kit (Lonza, Walkersville, USA)
was used for the quantiﬁcation of ATP in DBC. Brieﬂy, DBCwere incubat-
ed for 10minwith lysis buffer and at least for 5minwithmonitoring re-
agent. The emitted light (bioluminescence), which is linearly related to
ATP concentrations,was recorded using a luminometer (Victor X3). ATP
concentrations were quantiﬁed with a standard curve and normalized
to cellular protein content.2.6. Isolation of brain mitochondria
Brain (1/4) from the frontal region was homogenized in 2 mL of
mitochondrial respiration medium (MiR05, containing EGTA
(0.5 mmol/L), magnesium dichloride (3 mmol/L), lactobionic acid
(60 mmol/L), taurine (20 mmol/L), potassium dihydrogenphosphate
(10 mmol/L), HEPES (20 mmol/L), sucrose (110 mmol/L) and essen-
tially fatty acid-free bovine serum albumin (1 g/L)). Additionally, a
protease inhibitor (Roche, Mannheim, Germany) was added to the
medium. Samples were homogenized and centrifuged (1400 ×g,
7 min, 4 °C). The supernatant was collected and centrifuged again
for washing (1400 ×g, 3 min, 4 °C). Afterwards, the supernatant was
centrifuged to collect mitochondria in the pellet (10,000 ×g, 5 min,
4 °C). After resuspension, mitochondria were centrifuged for washing
(1400 ×g, 3 min, 4 °C) and once again (10,000 ×g, 5 min, 4 °C) to col-
lect the mitochondria in the pellet.2.7. Citrate synthase activity
An aliquot of the isolated mitochondria was immediately frozen in
liquid nitrogen for citrate synthase activity measurement. A reaction
medium containing 0.1 mmol/L 5,5′-dithiobis-2-nitrobenzoic acid
(DTNB), 0.5 mmol/L oxaloacetate, 50 μmol/L EDTA, 0.31 mmol/L acetyl
coenzyme A, 5 mmol/L triethanolamine hydrochloride, 0.25% Triton X-
100 and 0.1 mol/L Tris–HCl was mixed and incubated for 5 min at
30 °C. Then, 10 μL of mitochondria was added to the reaction medium
and citrate synthase activity was determined spectrophotometrically
at 412 nm.
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Protein contents were analyzed by the Lowry method using the
BioRadDC Protein Assay (Bio-Rad,Munich, Germany). Bovine serumal-
bumin was used as standard.
2.9. Statistics
Two-factorial ANOVA (factorswere diet and age)wasused to test for
effects of the diet and age as well as diet × age interactions. Where an
overall effect of the diet or age or a diet × age interaction was observed,
Bonferroni post-hoc tests were carried out to test for signiﬁcant differ-
ences between groups. To compare the weight of the mice, two-way
repeated-measures ANOVA was used. Data analyses were performed
using SPSS (IBM Corp., IBM SPSS Statistics for Windows, Version 22.0.
Armonk, NY, USA) and GraphPad Prism version 6.01 (GraphPad Soft-
ware, San Diego California, USA). Reported values are arithmetic
means with their standard error of the mean (SEM).
3. Results
3.1. Body weight development
Body weights were measured weekly (Fig. 1). Old mice were signiﬁ-
cantly heavier than youngmice (P b 0.000) at all times. No signiﬁcant dif-
ferences between control and curcumin-fed animals were observed
within each of the two age groups, with the exception of groups OC and
O500 at week 0 (P b 0.002). Diet (curcuminoids) did not inﬂuence the
weight of the mice.
3.2. Curcuminoid tissue concentrations
Total curcuminoid concentrations (the sum of free and conjugated
curcuminoids) weremeasured in the cerebellum, plasma, liver and kid-
ney of mice. Curcuminoids were neither detected in the brain (cerebel-
lum) of any of the groups, nor in any of the tissues in control animals.
Signiﬁcant effects for age and diet were detected for all three curcumi-
noids in plasma (Fig. 2A). Total plasma curcumin and DMC concentra-
tions were signiﬁcantly higher in old compared to young animals on
the same diets (Fig. 2A). BDMC concentrations were also higher in plas-
ma of oldmice after the administration of 2000mg curcuminoids per kg
diet compared to the corresponding youngmice (P=0.000, Fig 2A) and
concentrations were signiﬁcantly higher in the O2000 group compared
to the O500 group (P = 0.001). For plasma BDMC concentrations, anFig. 1.Mean (±SEM) body weights of young (3months) and old (18 months) male mice
fed a control diet (YC and OC, respectively) or identical diets supplementedwith curcumi-
noids at doses of 500 mg (Y500 and O500, respectively) or 2000 mg (Y2000 and O2000,
respectively) per kg diet for three weeks. Old mice were signiﬁcantly heavier than
young mice at each time point (P b 0.000; two-way repeated-measures ANOVA with
Bonferroni post-hoc tests). *Groups OC and O500 differed signiﬁcantly in body weight at
week 0 (P b 0.002), but no other differences in body weight were observed between
curcumin-fed animals and their respective age-matched control groups.age × diet interaction (P = 0.008) was observed. Such an interaction
was not seen for curcumin or DMC. In comparison to the corresponding
control group (OC), curcumin (P(O500 vs. OC) = 0.038, P(O2000 vs.
OC) = 0.003) and DMC (P(O500 vs. OC) = 0.039, P(O2000 vs. OC) =
0.001) concentrations were signiﬁcantly higher in the curcumin-fed
old mice but not in young mice and BDMC differed between O2000
and OC (P = 0.000).
In the liver, only diet inﬂuenced curcuminoid concentrations and in-
teractions between age and diet were not observed. Liver curcumin and
DMC concentrations in the Y2000 and O2000 groups were signiﬁcantly
higher compared to the Y500 (curcumin: P = 0.007, DMC: P = 0.000)
and O500 groups (curcumin: P = 0.006, DMC: P = 0.004), respectively.
DMC was undetectable after the consumption of 500 mg curcumin per
kg diet. BDMC contents were signiﬁcantly higher in O2000 compared to
O500 (P = 0.001, Fig. 2B). Young and old mice consuming 2000 mg cur-
cuminoids per kg diet had signiﬁcantly higher curcuminoid concentra-
tions compared to the corresponding control groups (YC and OC,
respectively, P b 0.05).
In the kidney, diet did, but age did not inﬂuence curcuminoid con-
centrations. No age × diet interactions were detected. Kidney curcumin
and BDMC contents were elevated in Y2000 and O2000 in comparison
to Y500 and O500, respectively (Fig. 2C). DMC concentrations could
only be measured after the administration of the higher curcumin
dose and O2000 had signiﬁcantly higher concentrations than O500
(P = 0.017, Fig 2C). Curcumin and BDMC were higher in the Y2000
and O2000 groups, and DMC only in O2000 compared to the young
and old control groups (P b 0.05).
3.3. Mitochondrial membrane potential in dissociated brain cells
The MMP serves as an indicator of the bioenergetic state of mito-
chondria [18]. For basal MMPwe could not detect any age or diet effects
or an interaction between age and diet (Fig. 3A). After damaging disso-
ciated brain cells with SNP, age (P=0.000) and diet (P=0.003) effects,
but no age × diet interactionswere observed. TheMMPwas signiﬁcant-
ly elevated in the oldmice compared to the corresponding young group
(Fig. 3B). Within the old group, the higher dose of curcumin lead to sig-
niﬁcantly higher MMP compared to the control (P = 0.016).
3.4. ATP concentrations in dissociated brain cells
Age, but not diet, signiﬁcantly affected (P = 0.026) basal ATP con-
centrations in dissociated brain cells. No age × diet interactions were
found. Basal ATP concentrations were signiﬁcantly higher in Y2000
compared to O2000 (P = 0.04, Fig. 3C), but did not differ between any
of the remaining groups. ATP concentrations in SNP-challenged cells
were similar in all groups (Fig. 3D) and no effects of age, diet or
age × diet interactions were observed.
3.5. Citrate synthase activity
Citrate synthase activity is a common quantitative marker for the
content of intact mitochondria [12]. Age affected citrate synthase activ-
ity (P= 0.045), whereas neither diet effects nor age × diet interactions
were evident (Fig. 3E). Old mice fed 500 mg curcuminoids per kg diet
(O500) had a signiﬁcantly higher citrate synthase activity compared to
the corresponding young animals (Y500; P = 0.045, Fig. 3E).
4. Discussion
We measured curcuminoid concentrations in cerebellum, plas-
ma, liver and kidney of 3-months young and 18 months-old mice
fed 500 or 2000 mg curcumin per kg diet for three weeks to investi-
gate if the tissue concentrations of these compounds are affected by
age. Plasma but not liver and kidney concentrations of curcumin
were higher in the old than in the young mice (Fig. 2). This is
Fig. 2.Mean (±SEM) concentrations of total curcumin, demethoxycurcumin (DMC) and bis-demethoxycurcumin (BDMC) in plasma [A], liver [B] and kidney [C] of 3-months young and
18-months old male mice fed a control diet (YC and OC, respectively) or identical diets supplemented with curcuminoids at doses of 500 mg (Y500 and O500, respectively) or 2000 mg
(Y2000 and O2000, respectively) per kg diet for three weeks. Curcuminoids were not detected in the control groups (YC and OC). Two-way ANOVA with Bonferroni post-hoc tests were
calculated to detect signiﬁcant differences. P-values for the effects of age, diet and age × diet interactions are reported above each graph. The P-values of Bonferroni post-hoc tests indicate
signiﬁcant differences between groups.
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young mice (Fig. 1) and thus ingested smaller doses per kg
bodyweight than their younger counterparts. One possible explana-
tion for these age-differences in curcumin plasma concentrations
could be that old mice may have decreased UDP-glucuronosyl trans-
ferase activities and thus a reduced metabolism and excretion [25].
The higher bodyweight of the older animals is also associated with
changes in body composition, such as increased total body fat and re-
duced total body water, which may alter the apparent volume of dis-
tribution [14] and thus pharmacokinetics of curcuminoids. Our
observation that liver and kidney tissue concentrations of the curcu-
minoids did not differ signiﬁcantly between young and old mice
(Fig. 2) is in line with this notion and suggests that the curcuminoids
may have been distributed differently to peripheral tissues in young
and old animals.Wedid not detect any curcuminoids in the cerebellum of our animals,
although curcuminoids, due to their lowmolecularweight and lipophilic-
ity, are generally able to cross the blood–brain-barrier [3]. These ﬁndings
are in agreement with our earlier observations that orally ingested
curcumin, probably because of limited absorption and rapid conjugation
by phase II enzymes, does not lead to measurable concentrations of
curcumin in the brain of mice [21]. Circumventing the gastro-intestinal
tract and thereby ﬁrst-pass metabolism in the small intestine and liver
by intraperitoneal injection of curcumin (100mg/kg bodyweight) results
in quantiﬁable concentrations of curcumin in the brain ofmice [21]. How-
ever, even though curcuminoidswere not detectable in the cerebellum of
ourmice, their intake resulted inmeasurable differences in themitochon-
drial function in dissociated brain cells (Fig. 3).
Dissociated brain cells of oldmicehad signiﬁcantly higherMMP than
those isolated from youngmice upon stimulationwith the stressor SNP,
Fig. 3. Basal MMP [A] and ATP [C], and MMP [B] and ATP [D] after treatment with SNP measured in dissociated brain cells and mean (±SEM) citrate synthase activity [E] measured in
isolated brain mitochondria of male young (3 months) and old (18 months) mice fed a control diet (YC and OC, respectively) or identical diets supplemented with curcuminoids at
doses of 500 mg (Y500 and O500, respectively) or 2000 mg (Y2000 and O2000, respectively) per kg diet for three weeks. Values are means with their standard errors. Two-way
ANOVA with Bonferroni post-hoc tests were calculated to detect signiﬁcant differences. P-values for the effects of age, diet and age × diet interactions are reported above each graph.
The P-values of Bonferroni post-hoc tests indicate signiﬁcant differences between groups.
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tion [26], and curcuminoid intake reinforced this effect (Fig. 3B). The
MMP of un-stimulated cells were similar between young and old as
well as between control-fed and curcuminoid-fed mice (Fig. 3A).
These observations suggest that old mitochondria are less susceptible
to stress-induced damage than young ones. In agreement,mitochondria
from senescent human umbilical vein endothelial cells were better
protected against oxidative stress than young cells; photodamage-
induced formation of reactive oxygen species led to loss of MMP in
young cells, whereas senescent cells were resistant [17]. Furthermore,
activities of antioxidant enzymes in brains of adult and aged mice are
higher than in young mice, which might result in a better protection
of mitochondria from reactive species [16].
The mitochondrial–lysosomal axis theory of aging suggests that the
number of defectivemitochondria within long-lived postmitotic cells in-
creases throughout the aging process and is accompanied by mitochon-
drial enlargement and decreased ATP production [23]. In accordance
with this, we observed a trend toward higher basal ATP concentrations
in the young animals fed control diets or 500 mg curcuminoids per kg
diet compared to their respective old counterparts, and signiﬁcantly
higher ATP in the Y2000 compared to the O2000 group (P b 0.05,
Fig. 3C). Curcuminoid-feeding, however, did not affect ATP concentra-
tions. We previously observed a similar trend toward increased MMP
and ATP in mice of the fast-aging strain senescence-accelerated mouse-
prone 8 (SAMP8) fed with 500 mg curcuminoids per kg diet for ﬁve
months [6]. The supplementation of transgenic APOE3 and APOE4 mice
with 2000mg curcuminoids/kg diet for threemonths increased ATP con-
centrations numerically in APOE3 and signiﬁcantly in APOE4 mice in
comparisonwith their respective control-fed animals [5]. In both studies,
the expression of the master regulator of mitochondrial biogenesisperoxisome proliferator-activated receptor γ coactivator-1α (PGC1α)
was higher in the curcumin-fed than in the respective control animals
[5,6], suggesting that curcumin may improve mitochondrial function
by increasing mitochondrial content. In our present study, citrate syn-
thase activity, a quantitative marker for the amount of intact mitochon-
dria, differed in young and old animals fed 500 mg curcuminoids per
kg diet, but not in those fed 2000mg/kg diet (Fig. 3E) [15]. This is in con-
trast to a previously reported study feeding Thy1-APPSL transgenicmice,
a mouse model for Alzheimer's disease, for three weeks with 500 mg
curcumin/kg diet of a highly bioavailable micellar formulation [22]
resulting in signiﬁcantly increased MMP and numerically increased
ATP levels, but unchanged citrate synthase activity compared to the con-
trol [20]. This discrepancy in the activity of curcuminoids onmitogenesis
might be due to the use of different curcuminoid formulations (highly
bioavailable curcuminoid micelles vs. native curcumin powder) and an-
imal models (genetically modiﬁed mice (Alzheimer's disease model) vs.
young and old wildtype mice (aging model)).
5. Conclusions
To the best of our knowledge, our ﬁndings of higher curcuminoid
plasma concentrations in 18- compared to 3-months-oldmice fed iden-
tical doses of curcuminoids are theﬁrst evidence that agemay be an im-
portant determinant of curcumin plasma concentrations. Further
studies are warranted to better understand potential age-differences
in the absorption, metabolism, distribution, and elimination of curcumi-
noids. Dissociated brain cells from curcumin-fed animals were some-
what more resistant to stress-induced decreases in mitochondrial
function, but overall, only minor differences in mitochondrial function
were observed between young and old mice.
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